HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emerging role of monoclonal antibodies in the treatment of IgA nephropathy.

AbstractINTRODUCTION:
IgA nephropathy is the most common primary glomerulonephritis worldwide. Immune complexes, composed of galactose-deficient IgA1 and Gd-IgA1 autoantibodies, are deposited in the mesangial area of the glomeruli where they induce complement-mediated inflammation. This may result in the reduced kidney function, which can progress to end-stage kidney disease. Treatment options are very limited. Treatments which directly affect the formation of pathogenic Gd-IgA1 antibodies and anti-Gd-IgA1 antibody-containing immune complexes are needed.
AREAS COVERED:
This article reviews potential therapies, namely monoclonal antibodies, that may affect the main axis of pathogenesis of IgA nephropathy with a discussion of their potential impact on the outcome of IgAN. PubMed was used to perform the literature search, which included papers on "treatment of IgA nephropathy"combined with "biological therapy", or 'monoclonal antibodies, atacicept, sibeprenlimab, rituximab, felzartamab, narsoplimab, iptacopan' published up to 2023.
EXPERT OPINION:
The new treatment options are aimed at the immunopathogenesis of IgAN, including depletion or modulation of Gd-IgA1 producing B cells, plasma cells, alternate or lectin pathway of complement. Monoclonal antibodies may target both B cells and T cells and also the factors needed for their activation and survival, e.g. BAFF or APRIL.
AuthorsDita Maixnerova, Vladimir Tesar
JournalExpert opinion on biological therapy (Expert Opin Biol Ther) Vol. 23 Issue 5 Pg. 419-427 (05 2023) ISSN: 1744-7682 [Electronic] England
PMID37183663 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
Chemical References
  • galactosyl-deficient IgA1
  • Antibodies, Monoclonal
  • Antigen-Antibody Complex
  • Immunoglobulin A
  • Galactose
Topics
  • Humans
  • Glomerulonephritis, IGA (drug therapy)
  • Antibodies, Monoclonal (therapeutic use)
  • Antigen-Antibody Complex
  • Immunoglobulin A (metabolism)
  • Galactose (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: